Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology

Eur Heart J. 2021 Dec 21;42(48):4978-4980. doi: 10.1093/eurheartj/ehab708.

Authors

Lavanya Kondapalli¹, Tomas G Neilan²

Affiliations

¹ Department of Medicine, Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
² Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

PMID: 34624092
DOI: 10.1093/eurheartj/ehab708

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biology
Cardiovascular Diseases*
Humans
Immune Checkpoint Inhibitors
Immune System
Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors